1 Influenza NA Inhibitor Market Overview 1.1 Product Overview and Scope of Influenza NA Inhibitor 1.2 Influenza NA Inhibitor Segment by Type 1.2.1 Global Influenza NA Inhibitor Market Value Comparison by Type (2023-2029) 1.2.2 Zanamivir 1.2.3 Oseltamivir 1.2.4 Peramivir 1.3 Influenza NA Inhibitor Segment by Application 1.3.1 Global Influenza NA Inhibitor Market Value by Application: (2023-2029) 1.3.2 Influenza A Treatment 1.3.3 Influenza B Treatment 1.4 Global Influenza NA Inhibitor Market Size Estimates and Forecasts 1.4.1 Global Influenza NA Inhibitor Revenue 2018-2029 1.4.2 Global Influenza NA Inhibitor Sales 2018-2029 1.4.3 Global Influenza NA Inhibitor Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Influenza NA Inhibitor Market Competition by Manufacturers 2.1 Global Influenza NA Inhibitor Sales Market Share by Manufacturers (2018-2023) 2.2 Global Influenza NA Inhibitor Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Influenza NA Inhibitor Average Price by Manufacturers (2018-2023) 2.4 Global Influenza NA Inhibitor Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Influenza NA Inhibitor, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Influenza NA Inhibitor, Product Type & Application 2.7 Influenza NA Inhibitor Market Competitive Situation and Trends 2.7.1 Influenza NA Inhibitor Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Influenza NA Inhibitor Players Market Share by Revenue 2.7.3 Global Influenza NA Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Influenza NA Inhibitor Retrospective Market Scenario by Region 3.1 Global Influenza NA Inhibitor Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Influenza NA Inhibitor Global Influenza NA Inhibitor Sales by Region: 2018-2029 3.2.1 Global Influenza NA Inhibitor Sales by Region: 2018-2023 3.2.2 Global Influenza NA Inhibitor Sales by Region: 2024-2029 3.3 Global Influenza NA Inhibitor Global Influenza NA Inhibitor Revenue by Region: 2018-2029 3.3.1 Global Influenza NA Inhibitor Revenue by Region: 2018-2023 3.3.2 Global Influenza NA Inhibitor Revenue by Region: 2024-2029 3.4 North America Influenza NA Inhibitor Market Facts & Figures by Country 3.4.1 North America Influenza NA Inhibitor Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Influenza NA Inhibitor Sales by Country (2018-2029) 3.4.3 North America Influenza NA Inhibitor Revenue by Country (2018-2029) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe Influenza NA Inhibitor Market Facts & Figures by Country 3.5.1 Europe Influenza NA Inhibitor Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Influenza NA Inhibitor Sales by Country (2018-2029) 3.5.3 Europe Influenza NA Inhibitor Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Influenza NA Inhibitor Market Facts & Figures by Country 3.6.1 Asia Pacific Influenza NA Inhibitor Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Influenza NA Inhibitor Sales by Country (2018-2029) 3.6.3 Asia Pacific Influenza NA Inhibitor Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.6.13 Philippines 3.7 Latin America Influenza NA Inhibitor Market Facts & Figures by Country 3.7.1 Latin America Influenza NA Inhibitor Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Influenza NA Inhibitor Sales by Country (2018-2029) 3.7.3 Latin America Influenza NA Inhibitor Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Influenza NA Inhibitor Market Facts & Figures by Country 3.8.1 Middle East and Africa Influenza NA Inhibitor Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Influenza NA Inhibitor Sales by Country (2018-2029) 3.8.3 Middle East and Africa Influenza NA Inhibitor Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 UAE 4 Segment by Type 4.1 Global Influenza NA Inhibitor Sales by Type (2018-2029) 4.1.1 Global Influenza NA Inhibitor Sales by Type (2018-2023) 4.1.2 Global Influenza NA Inhibitor Sales by Type (2024-2029) 4.1.3 Global Influenza NA Inhibitor Sales Market Share by Type (2018-2029) 4.2 Global Influenza NA Inhibitor Revenue by Type (2018-2029) 4.2.1 Global Influenza NA Inhibitor Revenue by Type (2018-2023) 4.2.2 Global Influenza NA Inhibitor Revenue by Type (2024-2029) 4.2.3 Global Influenza NA Inhibitor Revenue Market Share by Type (2018-2029) 4.3 Global Influenza NA Inhibitor Price by Type (2018-2029) 5 Segment by Application 5.1 Global Influenza NA Inhibitor Sales by Application (2018-2029) 5.1.1 Global Influenza NA Inhibitor Sales by Application (2018-2023) 5.1.2 Global Influenza NA Inhibitor Sales by Application (2024-2029) 5.1.3 Global Influenza NA Inhibitor Sales Market Share by Application (2018-2029) 5.2 Global Influenza NA Inhibitor Revenue by Application (2018-2029) 5.2.1 Global Influenza NA Inhibitor Revenue by Application (2018-2023) 5.2.2 Global Influenza NA Inhibitor Revenue by Application (2024-2029) 5.2.3 Global Influenza NA Inhibitor Revenue Market Share by Application (2018-2029) 5.3 Global Influenza NA Inhibitor Price by Application (2018-2029) 6 Key Companies Profiled 6.1 Green Cross 6.1.1 Green Cross Corporation Information 6.1.2 Green Cross Description and Business Overview 6.1.3 Green Cross Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2023) 6.1.4 Green Cross Influenza NA Inhibitor Product Portfolio 6.1.5 Green Cross Recent Developments/Updates 6.2 Roche 6.2.1 Roche Corporation Information 6.2.2 Roche Description and Business Overview 6.2.3 Roche Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2023) 6.2.4 Roche Influenza NA Inhibitor Product Portfolio 6.2.5 Roche Recent Developments/Updates 6.3 GlaxoSmithKline 6.3.1 GlaxoSmithKline Corporation Information 6.3.2 GlaxoSmithKline Description and Business Overview 6.3.3 GlaxoSmithKline Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2023) 6.3.4 GlaxoSmithKline Influenza NA Inhibitor Product Portfolio 6.3.5 GlaxoSmithKline Recent Developments/Updates 6.4 Henan DaKen Chemical 6.4.1 Henan DaKen Chemical Corporation Information 6.4.2 Henan DaKen Chemical Description and Business Overview 6.4.3 Henan DaKen Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Henan DaKen Chemical Influenza NA Inhibitor Product Portfolio 6.4.5 Henan DaKen Chemical Recent Developments/Updates 6.5 ATK Chemical 6.5.1 ATK Chemical Corporation Information 6.5.2 ATK Chemical Description and Business Overview 6.5.3 ATK Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2023) 6.5.4 ATK Chemical Influenza NA Inhibitor Product Portfolio 6.5.5 ATK Chemical Recent Developments/Updates 6.6 Chemwill Asia Co.,Ltd. 6.6.1 Chemwill Asia Co.,Ltd. Corporation Information 6.6.2 Chemwill Asia Co.,Ltd. Description and Business Overview 6.6.3 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Portfolio 6.6.5 Chemwill Asia Co.,Ltd. Recent Developments/Updates 6.7 Shionogi Co. 6.6.1 Shionogi Co. Corporation Information 6.6.2 Shionogi Co. Description and Business Overview 6.6.3 Shionogi Co. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Shionogi Co. Influenza NA Inhibitor Product Portfolio 6.7.5 Shionogi Co. Recent Developments/Updates 6.8 NeoPharm 6.8.1 NeoPharm Corporation Information 6.8.2 NeoPharm Description and Business Overview 6.8.3 NeoPharm Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2023) 6.8.4 NeoPharm Influenza NA Inhibitor Product Portfolio 6.8.5 NeoPharm Recent Developments/Updates 6.9 Moksha8 Pharma 6.9.1 Moksha8 Pharma Corporation Information 6.9.2 Moksha8 Pharma Description and Business Overview 6.9.3 Moksha8 Pharma Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2023) 6.9.4 Moksha8 Pharma Influenza NA Inhibitor Product Portfolio 6.9.5 Moksha8 Pharma Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Influenza NA Inhibitor Industry Chain Analysis 7.2 Influenza NA Inhibitor Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Influenza NA Inhibitor Production Mode & Process 7.4 Influenza NA Inhibitor Sales and Marketing 7.4.1 Influenza NA Inhibitor Sales Channels 7.4.2 Influenza NA Inhibitor Distributors 7.5 Influenza NA Inhibitor Customers 8 Influenza NA Inhibitor Market Dynamics 8.1 Influenza NA Inhibitor Industry Trends 8.2 Influenza NA Inhibitor Market Drivers 8.3 Influenza NA Inhibitor Market Challenges 8.4 Influenza NA Inhibitor Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Influenza NA Inhibitor Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Influenza NA Inhibitor Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Influenza NA Inhibitor Market Competitive Situation by Manufacturers in 2022 Table 4. Global Influenza NA Inhibitor Sales (Kilotons) of Key Manufacturers (2018-2023) Table 5. Global Influenza NA Inhibitor Sales Market Share by Manufacturers (2018-2023) Table 6. Global Influenza NA Inhibitor Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Influenza NA Inhibitor Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Influenza NA Inhibitor Average Price (US$/Kg) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Influenza NA Inhibitor, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Influenza NA Inhibitor, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Influenza NA Inhibitor, Product Type & Application Table 12. Global Key Manufacturers of Influenza NA Inhibitor, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Influenza NA Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza NA Inhibitor as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Influenza NA Inhibitor Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Influenza NA Inhibitor Sales by Region (2018-2023) & (Kilotons) Table 18. Global Influenza NA Inhibitor Sales Market Share by Region (2018-2023) Table 19. Global Influenza NA Inhibitor Sales by Region (2024-2029) & (Kilotons) Table 20. Global Influenza NA Inhibitor Sales Market Share by Region (2024-2029) Table 21. Global Influenza NA Inhibitor Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Influenza NA Inhibitor Revenue Market Share by Region (2018-2023) Table 23. Global Influenza NA Inhibitor Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Influenza NA Inhibitor Revenue Market Share by Region (2024-2029) Table 25. North America Influenza NA Inhibitor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Influenza NA Inhibitor Sales by Country (2018-2023) & (Kilotons) Table 27. North America Influenza NA Inhibitor Sales by Country (2024-2029) & (Kilotons) Table 28. North America Influenza NA Inhibitor Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Influenza NA Inhibitor Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Influenza NA Inhibitor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Influenza NA Inhibitor Sales by Country (2018-2023) & (Kilotons) Table 32. Europe Influenza NA Inhibitor Sales by Country (2024-2029) & (Kilotons) Table 33. Europe Influenza NA Inhibitor Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Influenza NA Inhibitor Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Influenza NA Inhibitor Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Influenza NA Inhibitor Sales by Region (2018-2023) & (Kilotons) Table 37. Asia Pacific Influenza NA Inhibitor Sales by Region (2024-2029) & (Kilotons) Table 38. Asia Pacific Influenza NA Inhibitor Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Influenza NA Inhibitor Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Influenza NA Inhibitor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Influenza NA Inhibitor Sales by Country (2018-2023) & (Kilotons) Table 42. Latin America Influenza NA Inhibitor Sales by Country (2024-2029) & (Kilotons) Table 43. Latin America Influenza NA Inhibitor Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Influenza NA Inhibitor Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Influenza NA Inhibitor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Influenza NA Inhibitor Sales by Country (2018-2023) & (Kilotons) Table 47. Middle East & Africa Influenza NA Inhibitor Sales by Country (2024-2029) & (Kilotons) Table 48. Middle East & Africa Influenza NA Inhibitor Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Influenza NA Inhibitor Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Influenza NA Inhibitor Sales (Kilotons) by Type (2018-2023) Table 51. Global Influenza NA Inhibitor Sales (Kilotons) by Type (2024-2029) Table 52. Global Influenza NA Inhibitor Sales Market Share by Type (2018-2023) Table 53. Global Influenza NA Inhibitor Sales Market Share by Type (2024-2029) Table 54. Global Influenza NA Inhibitor Revenue (US$ Million) by Type (2018-2023) Table 55. Global Influenza NA Inhibitor Revenue (US$ Million) by Type (2024-2029) Table 56. Global Influenza NA Inhibitor Revenue Market Share by Type (2018-2023) Table 57. Global Influenza NA Inhibitor Revenue Market Share by Type (2024-2029) Table 58. Global Influenza NA Inhibitor Price (US$/Kg) by Type (2018-2023) Table 59. Global Influenza NA Inhibitor Price (US$/Kg) by Type (2024-2029) Table 60. Global Influenza NA Inhibitor Sales (Kilotons) by Application (2018-2023) Table 61. Global Influenza NA Inhibitor Sales (Kilotons) by Application (2024-2029) Table 62. Global Influenza NA Inhibitor Sales Market Share by Application (2018-2023) Table 63. Global Influenza NA Inhibitor Sales Market Share by Application (2024-2029) Table 64. Global Influenza NA Inhibitor Revenue (US$ Million) by Application (2018-2023) Table 65. Global Influenza NA Inhibitor Revenue (US$ Million) by Application (2024-2029) Table 66. Global Influenza NA Inhibitor Revenue Market Share by Application (2018-2023) Table 67. Global Influenza NA Inhibitor Revenue Market Share by Application (2024-2029) Table 68. Global Influenza NA Inhibitor Price (US$/Kg) by Application (2018-2023) Table 69. Global Influenza NA Inhibitor Price (US$/Kg) by Application (2024-2029) Table 70. Green Cross Corporation Information Table 71. Green Cross Description and Business Overview Table 72. Green Cross Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023) Table 73. Green Cross Influenza NA Inhibitor Product Table 74. Green Cross Recent Developments/Updates Table 75. Roche Corporation Information Table 76. Roche Description and Business Overview Table 77. Roche Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023) Table 78. Roche Influenza NA Inhibitor Product Table 79. Roche Recent Developments/Updates Table 80. GlaxoSmithKline Corporation Information Table 81. GlaxoSmithKline Description and Business Overview Table 82. GlaxoSmithKline Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023) Table 83. GlaxoSmithKline Influenza NA Inhibitor Product Table 84. GlaxoSmithKline Recent Developments/Updates Table 85. Henan DaKen Chemical Corporation Information Table 86. Henan DaKen Chemical Description and Business Overview Table 87. Henan DaKen Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023) Table 88. Henan DaKen Chemical Influenza NA Inhibitor Product Table 89. Henan DaKen Chemical Recent Developments/Updates Table 90. ATK Chemical Corporation Information Table 91. ATK Chemical Description and Business Overview Table 92. ATK Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023) Table 93. ATK Chemical Influenza NA Inhibitor Product Table 94. ATK Chemical Recent Developments/Updates Table 95. Chemwill Asia Co.,Ltd. Corporation Information Table 96. Chemwill Asia Co.,Ltd. Description and Business Overview Table 97. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023) Table 98. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Table 99. Chemwill Asia Co.,Ltd. Recent Developments/Updates Table 100. Shionogi Co. Corporation Information Table 101. Shionogi Co. Description and Business Overview Table 102. Shionogi Co. Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023) Table 103. Shionogi Co. Influenza NA Inhibitor Product Table 104. Shionogi Co. Recent Developments/Updates Table 105. NeoPharm Corporation Information Table 106. NeoPharm Description and Business Overview Table 107. NeoPharm Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023) Table 108. NeoPharm Influenza NA Inhibitor Product Table 109. NeoPharm Recent Developments/Updates Table 110. Moksha8 Pharma Corporation Information Table 111. Moksha8 Pharma Description and Business Overview Table 112. Moksha8 Pharma Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023) Table 113. Moksha8 Pharma Influenza NA Inhibitor Product Table 114. Moksha8 Pharma Recent Developments/Updates Table 115. Key Raw Materials Lists Table 116. Raw Materials Key Suppliers Lists Table 117. Influenza NA Inhibitor Distributors List Table 118. Influenza NA Inhibitor Customers List Table 119. Influenza NA Inhibitor Market Trends Table 120. Influenza NA Inhibitor Market Drivers Table 121. Influenza NA Inhibitor Market Challenges Table 122. Influenza NA Inhibitor Market Restraints Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Influenza NA Inhibitor Figure 2. Global Influenza NA Inhibitor Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Influenza NA Inhibitor Market Share by Type in 2022 & 2029 Figure 4. Zanamivir Product Picture Figure 5. Oseltamivir Product Picture Figure 6. Peramivir Product Picture Figure 7. Global Influenza NA Inhibitor Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Influenza NA Inhibitor Market Share by Application in 2022 & 2029 Figure 9. Influenza A Treatment Figure 10. Influenza B Treatment Figure 11. Global Influenza NA Inhibitor Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 12. Global Influenza NA Inhibitor Market Size (2018-2029) & (US$ Million) Figure 13. Global Influenza NA Inhibitor Sales (2018-2029) & (Kilotons) Figure 14. Global Influenza NA Inhibitor Average Price (US$/Kg) & (2018-2029) Figure 15. Influenza NA Inhibitor Report Years Considered Figure 16. Influenza NA Inhibitor Sales Share by Manufacturers in 2022 Figure 17. Global Influenza NA Inhibitor Revenue Share by Manufacturers in 2022 Figure 18. The Global 5 and 10 Largest Influenza NA Inhibitor Players: Market Share by Revenue in 2022 Figure 19. Influenza NA Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 20. Global Influenza NA Inhibitor Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 21. North America Influenza NA Inhibitor Sales Market Share by Country (2018-2029) Figure 22. North America Influenza NA Inhibitor Revenue Market Share by Country (2018-2029) Figure 23. U.S. Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 24. Canada Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 25. Europe Influenza NA Inhibitor Sales Market Share by Country (2018-2029) Figure 26. Europe Influenza NA Inhibitor Revenue Market Share by Country (2018-2029) Figure 27. Germany Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. France Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 29. U.K. Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 30. Italy Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. Russia Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. Asia Pacific Influenza NA Inhibitor Sales Market Share by Region (2018-2029) Figure 33. Asia Pacific Influenza NA Inhibitor Revenue Market Share by Region (2018-2029) Figure 34. China Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. Japan Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 36. South Korea Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 37. India Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. Australia Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. Taiwan Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. Indonesia Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Thailand Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Malaysia Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Philippines Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Latin America Influenza NA Inhibitor Sales Market Share by Country (2018-2029) Figure 45. Latin America Influenza NA Inhibitor Revenue Market Share by Country (2018-2029) Figure 46. Mexico Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Brazil Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 48. Argentina Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 49. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Country (2018-2029) Figure 50. Middle East & Africa Influenza NA Inhibitor Revenue Market Share by Country (2018-2029) Figure 51. Turkey Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 52. Saudi Arabia Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 53. UAE Influenza NA Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million) Figure 54. Global Sales Market Share of Influenza NA Inhibitor by Type (2018-2029) Figure 55. Global Revenue Market Share of Influenza NA Inhibitor by Type (2018-2029) Figure 56. Global Influenza NA Inhibitor Price (US$/Kg) by Type (2018-2029) Figure 57. Global Sales Market Share of Influenza NA Inhibitor by Application (2018-2029) Figure 58. Global Revenue Market Share of Influenza NA Inhibitor by Application (2018-2029) Figure 59. Global Influenza NA Inhibitor Price (US$/Kg) by Application (2018-2029) Figure 60. Influenza NA Inhibitor Value Chain Figure 61. Influenza NA Inhibitor Production Process Figure 62. Channels of Distribution (Direct Vs Distribution) Figure 63. Distributors Profiles Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Green Cross Roche GlaxoSmithKline Henan DaKen Chemical ATK Chemical Chemwill Asia Co.,Ltd. Shionogi Co. NeoPharm Moksha8 Pharma